zurzuvae
Generic: zuranolone
Labeler: biogen ma inc.Drug Facts
Product Profile
Brand Name
zurzuvae
Generic Name
zuranolone
Labeler
biogen ma inc.
Dosage Form
CAPSULE
Routes
Active Ingredients
zuranolone 30 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
64406-031
Product ID
64406-031_61d04f88-eafb-40e4-ac63-62d083d14acf
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA217369
DEA Schedule
civ
Listing Expiration
2027-12-31
Marketing Start
2023-10-31
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
64406031
Hyphenated Format
64406-031
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
zurzuvae (source: ndc)
Generic Name
zuranolone (source: ndc)
Application Number
NDA217369 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 30 mg/1
Packaging
- 1 BOTTLE in 1 CARTON (64406-031-01) / 14 CAPSULE in 1 BOTTLE
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "61d04f88-eafb-40e4-ac63-62d083d14acf", "openfda": {"nui": ["N0000194006", "N0000193997"], "unii": ["7ZW49N180B"], "rxcui": ["2669910", "2669916", "2669918", "2669920", "2669922", "2669924"], "spl_set_id": ["f18e53b0-d0bb-422d-8de7-ab64b7292b29"], "pharm_class_epc": ["Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC]"], "pharm_class_moa": ["GABA A Receptor Positive Modulators [MoA]"], "manufacturer_name": ["Biogen MA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (64406-031-01) / 14 CAPSULE in 1 BOTTLE", "package_ndc": "64406-031-01", "marketing_start_date": "20231031"}], "brand_name": "ZURZUVAE", "product_id": "64406-031_61d04f88-eafb-40e4-ac63-62d083d14acf", "dosage_form": "CAPSULE", "pharm_class": ["GABA A Receptor Positive Modulators [MoA]", "Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC]"], "product_ndc": "64406-031", "dea_schedule": "CIV", "generic_name": "zuranolone", "labeler_name": "Biogen MA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ZURZUVAE", "active_ingredients": [{"name": "ZURANOLONE", "strength": "30 mg/1"}], "application_number": "NDA217369", "marketing_category": "NDA", "marketing_start_date": "20231031", "listing_expiration_date": "20271231"}